# Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation

Study · id `cardio:ct-nct02666157` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02666157](<https://clinicaltrials.gov/study/NCT02666157>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02666157

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 3672 participants.

## Technical summary

Registry record NCT02666157. Randomized; no masking; primary purpose treatment. Start 2016-01 (registry gives no type); primary completion 2018-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 3672 participants (planned count; ClinicalTrials.gov record NCT02666157, source copy `cardio:ctgov-nct02666157-2016-02-17`, retrieved 2026-10-26)
- Start date: 2016-01 (registry gives no type) (ClinicalTrials.gov record NCT02666157, source copy `cardio:ctgov-nct02666157-2016-02-17`, retrieved 2026-10-26)
- Primary completion: 2018-12 (anticipated) (ClinicalTrials.gov record NCT02666157, source copy `cardio:ctgov-nct02666157-2016-02-17`, retrieved 2026-10-26)
- Completion: 2018-12 (anticipated) (ClinicalTrials.gov record NCT02666157, source copy `cardio:ctgov-nct02666157-2016-02-17`, retrieved 2026-10-26)
- Countries: Taiwan (ClinicalTrials.gov record NCT02666157, source copy `cardio:ctgov-nct02666157-2016-02-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02666157-2016-02-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation
- Acronym: DARING-AF
- Condition: Atrial Fibrillation
- Intervention (Drug): Dabigatran etexilate
- Intervention (Drug): Rivaroxaban
- Intervention (Drug): Apixaban
- Lead sponsor: National Cheng-Kung University Hospital
- Lead sponsor class: OTHER
- Collaborator: Tainan Municipal Hospital
- Collaborator class: OTHER
- Collaborator: E-DA Hospital
- Collaborator class: OTHER
- Collaborator: National Cheng-Kung University Hospital Dou-Liou Branch
- Collaborator class: UNKNOWN
- Collaborator: Ministry of Health and Welfare, Taiwan
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Rivaroxaban (`cardio:rivaroxaban`)
- Registry intervention name matches this record: Apixaban (`cardio:apixaban`)
- Registry lists this organization as the lead sponsor: National Cheng-Kung University Hospital (`cardio:org-national-cheng-kung-university-hospital`)
- Registry lists this organization as a collaborator: E-DA Hospital (`cardio:org-e-da-hospital`)
- Registry lists this organization as a collaborator: Ministry of Health and Welfare, Taiwan (`cardio:org-ministry-of-health-and-welfare-taiwan`)

## Provenance

Content hash: 63b351f8a04c86fb1b0d40118b19f9126b1c8677b72362b9d9d4b1d0a534d13a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
